Clinical Trial Detail

NCT ID NCT03141684
Title Atezolizumab in Treating Patients With Newly Diagnosed and Metastatic Alveolar Soft Part Sarcoma That Cannot Be Removed by Surgery
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

alveolar soft part sarcoma

Therapies

Atezolizumab

Age Groups: adult senior child

No variant requirements are available.